In the Spotlight
To Produce Effective Policy, Scientific Reviews Must Be Focused—In a column for Nature, University of Cambridge’s William J. Sutherland writes, “Society increasingly demands that policies are based on scientific evidence, as it should.
Yet policy-makers rarely refer to journal papers—the actual evidence—instead preferring to base decisions on summaries, reviews, and assessments.” He then goes on to call for a more concerted effort by scientists to ensure that their summaries, reviews, and assessments are more refined in scope to help policymakers and their aides more accurately interpret and use scientific research in their regulations. (12/4/13)
Settlement for Cleaner Air—The US Environmental Protection Agency (EPA) and Department of Justice (DOJ) have reached a settlement with Cabot Corporation as part of the US EPA’s effort to bring carbon black manufacturers into compliance with the Clean Air Act.
The manufacturer has agreed to spend $84 million to control air pollution at three of its facilities in Louisiana and Texas. A DOJ official says, “This agreement will serve as a model for how the industry can come into compliance with the Clean Air Act.” (11/21/13)
Sequester Affecting University Research and Positions—A new survey of leaders of public and private research universities reports that 70 percent of respondents have encountered research delays and fewer research grants since the congressional sequestration budget cuts began earlier this year.
The survey also revealed a reduction in undergraduate study research and graduate admissions. The Washington Post reports that sequester is likely to shrink federal funding for research and development at universities by almost $1 billion. (11/14/13)
Look at the Science, Not the Rhetoric—In a “Letter to the Editor” in The New York Times, SOT President Lois D. Lehman-McKeeman responds to an opinion column that touts the hazards of endocrine-disrupting chemicals. Dr. Lehman-McKeeman discusses the uncertainty surrounding endocrine-disrupting chemicals and encourages people to not get caught up in a perceived risk before the science has a chance to determine if an actual risk to human health exists. The full letter can be found on the Times’ website. (11/6/13)
American Public Trust in Government at a Low While Science Agencies Are Viewed Favorably—Public trust in the government has edged to a two-year low with only 19 percent of Americans trusting the government to do what is right “just about always” or “most of the time,” according to a new study by Pew Research. In comparison, Americans have favorable views of US scientific agencies, such as the Center for Disease Control (CDC), NASA, US Food and Drug Administration (US FDA), US Environmental Protection Agency (US EPA), and Department of Health and Human Services (HHS), which all received favorability scores above 60 percent. For more details on how Americans view the government, Congress, and the agencies, peruse Pew Research’s complete results. (10/23/13)
SOT Hosted a Luncheon Congressional Briefing on the Tools and Technologies for Toxicity Testing in the 21st Century.
CCT FutureTox—The Society Sponsored a Two-Day Workshop on FutureTox with more than 200 Professionals Attending.
Thomas: Bills Before Congress—A service provided by the Library of Congress which offers up-to-the-minute legislative information. Schedules for House, Senate, and Committee Hearings are also available. This site also provides access to the Federal Register, the official record of Congressional Activity.
Meet SOT’s Leadership
SOT is led by a group of full-time board members, called Councilors, who are elected by ballot by the full membership and who manage the affairs of SOT. Learn more about SOT’s leaders.
Issue and Position Statements
As part of the Society’s mission to build for the future of toxicology and to promote the recognition of Toxicology by increasing the reliance of policy, regulatory and corporate decision-makers on the science of Toxicology, SOT has developed a procedure for writing Issue Statements. This procedure takes precedent over the drafting of Position Statements because SOT represents many diverse audiences and our mission to external audiences is to present a balanced view of the science and ensure that all policy decisions on grounded on scientific information.
Briefings & Testimony
Toxicologist and scientists provide an important role in the implementation of science in regulatory and public policy decision-making. Learn more about SOT’s activities on Capitol Hill.
What Toxicologists Say
Several of SOT’s past presidents talked recently about toxicology and their experiences as members of SOT.
View what these toxicologists had to say.
The following series of articles are written by toxicologists who are members of the Society of Toxicology but do not necessarily represent the views of the Society. SOT has made every effort to provide the public with balanced, informational pieces to share our expert knowledge more broadly.
Endocrine Disruption—General Overview
Developing Safe Products Using Nanotechnology
Melamine Contamination of Infant Formulas: Lessons Learned
Inhaled Particles: From the Nose to the Brain?
Dietary Supplement Adulteration and Impact on Human Health
21st Century Validation Strategies—One Size No Longer Fits All
Breast Cancer As a Multifactorial Disease: Interaction of Genetics, Life Stage, and the Environment
Alternative Approaches to the Safety Assessment of Natural Ingredients and Extracts in Cosmetics
View the list of topics.